MeSH term
Frequency | Condition_Probility | Adult | 13 | 0.0 |
Aged | 5 | 0.0 |
Female | 25 | 0.0 |
Flow Cytometry | 2 | 0.0 |
G1 Phase/physiology | 2 | 2.0 |
Humans | 45 | 0.0 |
Middle Aged | 7 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 28 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Transfection | 3 | 0.0 |
Cell Cycle Proteins/genetics | 2 | 2.0 |
Comparative Study | 3 | 0.0 |
DNA Methylation | 5 | 0.0 |
DNA Mutational Analysis | 9 | 0.0 |
Gene Deletion | 4 | 0.0 |
Gene Silencing | 2 | 0.0 |
Genes, p16 | 2 | 2.0 |
Genes, ras | 3 | 1.0 |
Protein p16/genetics | 3 | 3.0 |
Protein-Serine-Threonine Kinases/genetics | 2 | 1.0 |
*Tumor Suppressor Proteins | 2 | 0.0 |
Animals | 6 | 0.0 |
Base Sequence | 7 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
DNA Primers | 3 | 0.0 |
Immunohistochemistry | 4 | 0.0 |
Mice | 2 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Peutz-Jeghers Syndrome/*genetics | 13 | 65.0 |
Protein-Serine-Threonine Kinases/*genetics | 20 | 6.0 |
Adenocarcinoma/*genetics/pathology | 2 | 2.0 |
Mutation | 7 | 0.0 |
Peutz-Jeghers Syndrome/*genetics/pathology | 2 | 100.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Alleles | 5 | 0.0 |
Exons/genetics | 4 | 0.0 |
Genetic Screening | 2 | 0.0 |
Male | 12 | 0.0 |
Pedigree | 7 | 0.0 |
Polymorphism, Single-Stranded Conformational | 6 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Germ-Line Mutation | 8 | 2.0 |
*Loss of Heterozygosity | 4 | 1.0 |
Microsatellite Repeats | 5 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Risk Factors | 5 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Disease Progression | 2 | 0.0 |
Family Health | 3 | 0.0 |
Genes, Tumor Suppressor | 3 | 0.0 |
Cell Cycle/*physiology | 2 | 0.0 |
Hela Cells | 3 | 0.0 |
Kinetics | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 7 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
*Genes, Tumor Suppressor | 2 | 0.0 |
Genotype | 3 | 0.0 |
*Mutation | 11 | 0.0 |
Genetic Markers | 3 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Phenotype | 6 | 0.0 |
Gene Expression | 2 | 0.0 |
Loss of Heterozygosity | 8 | 0.0 |
Chromosomes, Human, Pair 19/genetics | 3 | 2.0 |
Mutation, Missense | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Child | 2 | 0.0 |
*Germ-Line Mutation | 3 | 0.0 |
Peutz-Jeghers Syndrome/*enzymology/genetics | 2 | 100.0 |
Exons | 2 | 0.0 |
Ovarian Neoplasms/*genetics | 2 | 0.0 |
Chromosomes, Human, Pair 19 | 4 | 2.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
*Gene Deletion | 2 | 0.0 |
